Management of diverticular disease: is there room for rifaximin?
about
Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular diseaseRifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.Rifaximin in the management of colonic diverticular disease.Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.
P2860
Management of diverticular disease: is there room for rifaximin?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Management of diverticular disease: is there room for rifaximin?
@ast
Management of diverticular disease: is there room for rifaximin?
@en
type
label
Management of diverticular disease: is there room for rifaximin?
@ast
Management of diverticular disease: is there room for rifaximin?
@en
prefLabel
Management of diverticular disease: is there room for rifaximin?
@ast
Management of diverticular disease: is there room for rifaximin?
@en
P2093
P2860
P356
P1433
P1476
Management of diverticular disease: is there room for rifaximin?
@en
P2093
Claudio Papi
Lucio Capurso
Maurizio Koch
P2860
P304
P356
10.1159/000081997
P478
51 Suppl 1
P577
2005-01-01T00:00:00Z